CAS 1869928-62-0

Cofetuzumab

CAS: 1869928-62-0

Cofetuzumab

Reinheit: ≥95%

Ref: 54-BUP20249

Cofetuzumab

CAS: 1869928-62-0

Cofetuzumab (PF-06523435) is a antibody targeting protein tyrosine kinase 7 (PTK7), which can be used to synthesize ADC compounds like cofetuzumab pelidotin.

Reinheit: >95%

Farbe und Form: Liquid

Molekulargewicht: 146.7 kDa

Ref: TM-T82696

Cofetuzumab

CAS: 1869928-62-0

Humanized anti-PTK7 monoclonal antibody

Ref: 3D-CLA1497